EU Drugs Agency warns vaping products may become a vehicle for harmful substances

The EU Drugs Agency (EUDA) has raised concerns that vaping products are increasingly being used to distribute harmful substances, specifically synthetic and semi-synthetic forms of cannabis and new synthetic opioids. This trend is driven by the evolving and complex drug markets in Europe, where the variety of substances is becoming more unpredictable and potent. The agency's latest annual report highlights that drug markets are adapting rapidly, with new psychoactive substances (NPSs) still emerging at a rate of about one per week. The report also notes a significant increase in the use of ketamine, with treatment admissions quadrupling since 2019. Furthermore, EUDA warns that drug trafficking networks are evading detection by diversifying their routes and methods, including the use of smaller ports and semi-submersibles. The agency emphasizes the serious public health risks posed by the wide availability of diverse, high-potency substances and the common practice of polysubstance use. It also points out the security implications of drug markets, particularly the exploitation of vulnerable young people by criminal groups. The report details the continued high consumption of cannabis and cocaine, noting that cocaine remains a leading cause of drug-induced deaths. EU Commissioner Magnus Brunner called for strong legal measures to prevent dangerous new products from flooding the market and to dismantle the business models of illegal traffickers. Finally, EUDA stressed the need for sustained investment in prevention, treatment, harm reduction, and social reintegration to address these complex challenges.

(Source：BreakingNews.ie)